-       Report 
   - September 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - September 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - February 2025
    -  182 Pages 
    Global
   
   From       €4038EUR$4,500USD£3,544GBP 
                -       Report 
   - May 2025
    -  93 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                -       Report 
   - January 2025
    -  210 Pages 
    Global
   
   From       €4482EUR$4,995USD£3,934GBP 
                 -       Report 
   - January 2025
    -  120 Pages 
    United States
   
   From       €2234EUR$2,490USD£1,961GBP 
                -       Report 
   - February 2021
    -  117 Pages 
    United States
   
   From       €4442EUR$4,950USD£3,898GBP 
                -       Report 
   - October 2024
    -  98 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2378EUR$2,650USD£2,087GBP 
                        Etomidate is an intravenous anesthetic drug used for induction of general anesthesia. It is a short-acting, non-barbiturate hypnotic agent that produces rapid onset of anesthesia with minimal cardiovascular and respiratory depression. It is commonly used for short surgical procedures, such as endoscopy, and is also used for rapid sequence intubation. Etomidate is metabolized by the liver and excreted by the kidneys, and has a relatively short duration of action.
Etomidate is one of several    anesthetic drugs used in the market, which also includes barbiturates, benzodiazepines, and propofol. It is often used in combination with other drugs to provide a balanced anesthetic effect. Etomidate is generally considered to be a safe and effective anesthetic drug, with few side effects.
Some companies in the Etomidate market include Hospira, Mylan, Fresenius Kabi, and Teva Pharmaceuticals. Show Less   Read more